Legend Biotech Corp (LEGN) Net margin 2018–2025
Legend Biotech Corp (LEGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-28.8%FY2025 · since FY2018: -5.7% → -28.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -28.8% | -0.6 pp |
| FY2024 | -28.2% | +153.6 pp |
| FY2023 | -181.8% | +705.1 pp |
| FY2022 | -886.9% | -300.5 pp |
| FY2021 | -586.4% | -231.2 pp |
| FY2020 | -355.2% | -185.8 pp |
| FY2019 | -169.4% | -163.7 pp |
| FY2018 | -5.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice